BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25174547)

  • 1. Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.
    Molica S; Giannarelli D; Mirabelli R; Levato L; Gentile M; Lentini M; Morabito F
    Expert Rev Hematol; 2014 Oct; 7(5):691-5. PubMed ID: 25174547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
    Molica S; Mauro FR; Giannarelli D; Lauria F; Cortelezzi A; Brugiatelli M; Liso V; Cuneo A; Foà R
    Haematologica; 2011 Feb; 96(2):277-83. PubMed ID: 20971821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Chronic Lymphocytic Leukemia Using iwCLL 2018 Compared with NCI-WG96 Criteria in Cipto Mangunkusumo Hospital: A Practical Consideration in Resource Limited Setting.
    Sukrisman L; Rinaldi I
    Acta Med Indones; 2022 Oct; 54(4):531-539. PubMed ID: 36624709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.
    Molica S; Levato D; Dattilo A
    Haematologica; 1999 Dec; 84(12):1094-9. PubMed ID: 10586211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada.
    Healey R; Patel JL; de Koning L; Naugler C
    Leuk Res; 2015 Apr; 39(4):429-34. PubMed ID: 25703352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
    J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
    Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
    Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?].
    Schindhelm RK; van Marwijk Kooy MR; Coenen JL; Huijgens PC; Kuiper-Kramer PA
    Ned Tijdschr Geneeskd; 2010; 154():A1520. PubMed ID: 20482911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
    Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
    Shanafelt TD; Kay NE; Call TG; Zent CS; Jelinek DF; LaPlant B; Morice WG; Hanson CA
    Leuk Res; 2008 Sep; 32(9):1458-61. PubMed ID: 18179821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.